Prematurity Clinical Trial
Official title:
Randomized Trial of Hydrolyzed Protein Premature Formula
Premature infants fed with a protein hydrolyzed formula will have better tolerance needing shorter time to achieve full feeds when compared to those fed with an intact protein formula.
The study formula is a 100% whey protein partially hydrolyzed (vs 60/40 Whey:Casein ratio of
regular premature formulas) Because the tolerance and availability of breast milk is not
predictable at the time of enrollment all the eligible premature infants will be randomized
and assigned to the study or control group. Infants will receive formula, either because
breast milk is not available or because indicated by the attending physician and switched to
formula, They will be fed, depending of the group to what they are assigned, with either the
PH formula for the study group or regular premature formula for the control group.
Randomization and blinding All eligible infants with parental consent will be randomized to
either the study group to receive protein hydrolyzed formula (PH group) or to the control
group to receive standard premature formula. Randomization will be stratified by 2 birth
weight categories (500-1000 g and 1001-1500 g). The purpose of such stratification is to
avoid imbalance between groups for factors that may influence outcome and is based on the
different morbidity in different birth weight categories.
Masked randomization will be performed in a way that avoids the possibility of knowledge of
treatment assignment at the time that eligibility is assessed and consent is sought. Only
the person in charge of preparing the control or study formula will be aware of the infant's
assignment group. Caregivers will remain masked to treatment group.
Study population Preterm newborns admitted to the neonatal intensive care unit with a birth
weight 500-1500 g and who survive more than 3 days.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Completed |
NCT05322161 -
Yoga in the NICU for Parents Study
|
N/A | |
Recruiting |
NCT04542096 -
Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
|
||
Recruiting |
NCT04911452 -
Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants
|
N/A | |
Recruiting |
NCT02901652 -
NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT02148965 -
Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial
|
N/A | |
Completed |
NCT02273843 -
A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis
|
Phase 1 | |
Terminated |
NCT02032511 -
Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP)
|
N/A | |
Completed |
NCT01721629 -
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
|
N/A | |
Terminated |
NCT01819532 -
Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks
|
N/A | |
Completed |
NCT00951860 -
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort
|
N/A | |
Completed |
NCT01523769 -
Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants
|
N/A | |
Completed |
NCT01478711 -
Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants
|
N/A | |
Completed |
NCT00787124 -
Transfusions and Nitric Oxide Level in Preterm Infants
|
||
Completed |
NCT00749008 -
Study of Generalized Movements for Early Prediction of Cerebral Palsy
|
N/A | |
Terminated |
NCT01208493 -
Dietary Protein in the Very-low-birth-weight Infant
|
N/A | |
Completed |
NCT00527956 -
Facilitation and Barriers to Breastfeeding in the NICU
|
N/A | |
Terminated |
NCT00486395 -
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
|
Phase 3 | |
Completed |
NCT03372590 -
NEO Rehab for Infants at Risk of Cerebral Palsy
|
N/A | |
Completed |
NCT00033917 -
Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
|
Phase 3 |